• Survey: 3 Surprising Things BioPharma Can Learn about Patients’ Perceptions
    Survey: 3 Surprising Things BioPharma Can Learn about Patients’ Perceptions

    By Jean McCoy Reverba EVP, Partnerships Perception is reality, as the saying goes. But sometimes, we can be too entrenched in our daily routine, entrenched in our field, and we…

  • Reverba Co-Founder and CEO Cheryl Lubbert named Women Leaders in Business Gold Globee® Winner
    Reverba Co-Founder and CEO Cheryl Lubbert named Women Leaders in Business Gold Globee® Winner

    – Awards recognize individuals and women-led organizations who have demonstrated extraordinary dedication and innovation – SEATTLE – October 18, 2023 – Reverba, a leading global patient engagement company, today announced…

  • Authenticity In An Automated World: Surprising Guidance From Healthcare
    Authenticity In An Automated World: Surprising Guidance From Healthcare

    Published in Forbes By: Cheryl Lubbert, Forbes Councils Member When faced with online customer service “agents” who don’t have real answers or solutions for specific problems, email responses that don’t…

  • Embrace the Rainbow: Three Tips to Make DEI Foundational In Your Clinical Program
    Embrace the Rainbow: Three Tips to Make DEI Foundational In Your Clinical Program

    By: Jean McCoy Diversity in clinical trials is a hot-button topic, with attention and programs ranging from legislation (both proposed and passed) to industry conference panels and required continuing education…

  • Our Commitment to Patient Data Security and Privacy: Ongoing SOC 2®, Type II Certification
    Our Commitment to Patient Data Security and Privacy: Ongoing SOC 2®, Type II Certification

    SOC 2 certification aligns Reverba with world-class organizations achieving the highest level of security and compliance for data management for service organizations – SEATTLE – April 20, 2023 – Reverba,…

  • The Patient Voice: Industry and Advocates Speak in Harmony
    The Patient Voice: Industry and Advocates Speak in Harmony

    By: Jean McCoy A generation ago, HIV/AIDS patients had to “Act Up” to be heard. A recent virtual summit shows how much has changed since the days of that pioneering…

  • How Can We Have More Successful Rare Disease Trials?
    How Can We Have More Successful Rare Disease Trials?

    By: Reverba Clinical Partnerships Team More than 300 million people around the world live with a rare disease—that is, a condition that affects fewer than 1 in 2,000. Although each…

  • Patient insights on trials: improving trust, the experience, and diversity.
    Patient insights on trials: improving trust, the experience, and diversity.

    By: Reverba Clinical Partnerships Team We have all made New Year’s resolutions – some we keep, and some never come to fruition. What are your goals as an organization? You…

  • Patient Engagement: What Matters Most in 2023. A retrospective by Cheryl Lubbert
    Patient Engagement: What Matters Most in 2023. A retrospective by Cheryl Lubbert

    By: Cheryl Lubbert Think about 2022 – what stands out to you the most? For me, it’s how often we heard that things were “returning to normal” after two years…

  • Reverba Celebrates 20 Years of Amplifying Patient Voices
    Reverba Celebrates 20 Years of Amplifying Patient Voices

    – 20th Anniversary demonstrates Reverba has the staying power and adaptability to continue leading the way in patient engagement solutions for life sciences companies – SEATTLE – October 10, 2022…

  • It’s Our Anniversary: 20 Years, 20 Reasons to Believe
    It’s Our Anniversary: 20 Years, 20 Reasons to Believe

    By: Cheryl Lubbert Today, we turn 20. Sixteen may be sweet, but twenty means so much more when you’re talking about the lifetime of a company. In an age of…

  • HBA Rising Star: Stephanie Hayes
    HBA Rising Star: Stephanie Hayes

    By: Cheryl Lubbert As a pioneer in patient engagement, Reverba wouldn’t be where it is today without a talented team of individuals in roles spanning the organization. Every so often,…